GNLX

Genelux Corporation

2.29 USD
+0.01 (+0.44%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Genelux Corporation stock is down -12.6% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 1 June’s closed higher than May. 100% of analysts rate it a buy.

About Genelux Corporation

Genelux is a clinical-stage biopharmaceutical company focused on developing a pipeline of next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Our principal executive offices are located at 2625 Townsgate Road, Suite 230, Westlake Village, California.

  • Benchmark
    Mon Jun 3, 11:59
    buy
    confirm
  • Benchmark
    Fri May 31, 11:11
    buy
    confirm